Search by Drug Name or NDC
NDC 59088-0524-54 Dotremin 1; 250 mg/1; ug/1 Details
Dotremin 1; 250 mg/1; ug/1
Dotremin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PureTek Corporation. The primary component is FOLIC ACID; VITAMIN D.
MedlinePlus Drug Summary
Cholecalciferol (vitamin D3) is used as a dietary supplement when the amount of vitamin D in the diet is not enough. People most at risk for vitamin D deficiency are older adults, breastfed infants, people with dark skin, obese people, and those with limited sun exposure, or gastrointestinal disease (GI; affecting the stomach or intestines) such as Crohn's disease or celiac disease. Cholecalciferol (vitamin D3) is also used along with calcium to prevent and treat bone diseases such as rickets (softening and weakening of bones in children caused by lack of vitamin D), osteomalacia (softening and weakening of bones in adults caused by lack of vitamin D), and osteoporosis (a condition in which the bones become thin and weak and break easily). Cholecalciferol (vitamin D3) is in a class of medications called vitamin D analogs. Cholecalciferol is needed by the body for healthy bones, muscles, nerves, and to support the immune system. It works by helping the body to use more of the calcium found in foods or supplements.
Related Packages: 59088-0524-54Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cholecalciferol (Vitamin D3)
Folic acid is used to treat or prevent folic acid deficiency. It is a B-complex vitamin needed by the body to manufacture red blood cells. A deficiency of this vitamin causes certain types of anemia (low red blood cell count).
Related Packages: 59088-0524-54Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Folic Acid
Product Information
NDC | 59088-0524 |
---|---|
Product ID | 59088-524_d5922f8a-7f55-7e96-e053-2a95a90a70a1 |
Associated GPIs | 82991502400335 |
GCN Sequence Number | 082759 |
GCN Sequence Number Description | vitamin D3/folic acid TABLET 250MCG-1MG ORAL |
HIC3 | C6D |
HIC3 Description | VITAMIN D PREPARATIONS |
GCN | 51357 |
HICL Sequence Number | 041600 |
HICL Sequence Number Description | CHOLECALCIFEROL (VIT D3)/FOLIC ACID |
Brand/Generic | Brand |
Proprietary Name | Dotremin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Folic Acid, Vitamin D3 |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 1; 250 |
Active Ingredient Units | mg/1; ug/1 |
Substance Name | FOLIC ACID; VITAMIN D |
Labeler Name | PureTek Corporation |
Pharmaceutical Class | Vitamin D [CS], Vitamin D [EPC] |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 59088-0524-54 (59088052454)
NDC Package Code | 59088-524-54 |
---|---|
Billing NDC | 59088052454 |
Package | 30 TABLET in 1 BOTTLE, PLASTIC (59088-524-54) |
Marketing Start Date | 2022-01-14 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL cd132db2-7ff7-a9eb-e053-2995a90a02c5 Details
DESCRIPTION
Dotremin™ is an orally administered prescription folate product for the dietary management of patients with unique nutritional needs requiring increased folate levels and Vitamin D supplementation due to Vitamin D deficiency.
Dotremin™ should be administered under the supervision of a licensed medical practitioner.
Each tablet contains:
Folate (as folic acid)……………………..1700 mcg DFE † (1000 mcg folic acid)
Vitamin D 3 (cholecalciferol)………....250 mcg (10,000 IU)
Each tablet contains the following inactive ingredients:
lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium carboxymethyl starch, stearic acid, DL-alpha- tocopheryl acetate.
† Dietary Folate Equivalent
INDICATIONS AND USAGE
CLINICAL PHARMACOLOGY
The
in vivo synthesis of the major biologically active metabolites of Vitamin D occurs in two steps. The first hydroxylation of ergocalciferol takes place in the liver (to 25-hydroxyvitamin D) and the second in the kidneys (to 1,25-dihydroxyvitamin D). Vitamin D metabolites promote the active absorption of calcium and phosphorus by the small intestine, thus elevating serum calcium and
phosphate levels sufficiently to permit bone mineralization. Vitamin D metabolites also mobilize calcium and phosphate from bone and probably increase the reabsorption of calcium and perhaps also of phosphate by the renal tubules.
There is a time lag of 10 to 24 hours between the administration of vitamin D and the initiation of its action in the body due to the necessity of synthesis of the active metabolites in the liver and kidneys. Parathyroid hormone is responsible for the regulation of this metabolism in the kidneys.
CONTRAINDICATIONS
WARNINGS AND PRECAUTIONS
KEEP OUT OF THE REACH OF CHILDREN.
Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breastfeeding. Consult your doctor.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
ADVERSE REACTIONS
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
Dotremin™ Tablets are supplied as round, light yellow tablets with one side scored, the other side plain and dispensed in child-resistant bottles of 30 tablets (NDC 59088-524-54*).
* This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels (AUG 2, 1973 FR 20750), requires an Rx on the label because of increased risk associated with masking of B 12 deficiency (pernicious anemia). Based on our assessment of the risk of obscuring pernicious anemia, this product requires licensed medical supervision, an Rx status, and a National Drug Code (NDC) or similarly-formatted product code, as required by pedigree reporting requirements and supply-chain control as well as in some cases, for insurance-reimbursement applications.
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence
STORAGE
Dotremin™
INGREDIENTS AND APPEARANCE
DOTREMIN
folic acid, vitamin d3 tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - PureTek Corporation (785961046) |